drugset / Trial / NCT00159640
Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effectiveness of PD-217,014 in the treatment of chronic pain following a shingles infection.
Timeline
- Start
- 2004-02
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PD-217,014 | Small molecule | — | — |
Indications
No indication recorded.